Navigation Links
S.L.E. Lupus Foundation Gala Raises Record $3.2 Million for Lupus

Bob Costas Presents Award to NBC Sports Producer Michael Weisman and Wife


NEW YORK, Dec. 5 /PRNewswire/ -- The 2007 S.L.E. Lupus Foundation's "Life Without Lupus" Gala raised more than $3.2 million for lupus, a national record for funds collected at a single event to support education, provide services, and nurture research for the chronic and often devastating autoimmune illness. Nearly 700 supporters attended the December 3rd black tie event at the Marriott Marquis in New York's Times Square.

The evening's program was emceed by NBC's dynamic Today Show host, Hoda Kotb and featured a rousing 30-minute set by Broadway star and Tony Award winner, Patti LuPone. A dramatic video featuring people with lupus cast a reflective mood in the crowd as they assembled for dinner in the candlelit ballroom. (View video at

Sportscaster Bob Costas introduced the award to the Weismans, describing the couple as a "team in life and work." Carol Weisman, who has lupus, and husband Michael Weisman, an Emmy Award-winning producer for NBC Sports, connect generations, personalities, and East Coast to West Coast through their countless contributions to lupus.

In Los Angeles, Carol galvanized support for the Foundation's west coast division, Lupus LA, helping it to become the presence in patient awareness and Hollywood involvement that it is today. Now in New York, Carol is a dynamic voice on the Foundation's board of directors and a passionate advocate for its national research partner, the Lupus Research Institute.

With clear admiration for Carol and the multitude of others in the room that campaign for lupus, Mistress of Ceremonies Kotb described gathering similar courage to speak out about her recent fight with breast cancer following a comment from a stranger on an airplane flight: "Don't hog your journey," he advised her. Be a force for change. The Weismans, Kotb said, are a model for doing just that.

The 2007 Scientific Leadership Award was given to Benjamin Schwartz, MD, PhD, professor of internal medicine at Washington University in St. Louis, whose sage and steady guidance has enabled the Lupus Research Institute to pioneer a powerful model for scientific discovery in lupus.

The 2007 Corporate Leadership Award was given to Aspreva Pharmaceuticals, in recognition of its vigorous work in developing evidence-based treatments for people with lupus and other long-neglected diseases.

"The name Aspreva is derived from the words aspirations, hopes, and dreams," said Aspreva Executive Vice President of Global Pharmaceutical Operations, Rick Goulburn, upon accepting the award for the company. "We've been inspired by you to aspire hope and dream for a life without lupus," he said. "And due to your work, we'll hopefully get there in the not-too-distant future."

About the S.L.E. Lupus Foundation

The S.L.E. Lupus Foundation, headquartered in New York and Los Angeles, is the leading lupus organizations in the country providing patient services, education, public awareness and funding for novel lupus research. For more information on lupus or the Foundation, visit

SOURCE S.L.E. Lupus Foundation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Preclinical study suggests organ-transplant drug may aid in lupus fight
2. Genes Boost Risk for Rheumatoid Arthritis, Lupus
3. The Will and Jada Smith Family Foundation and Maybelline Join Forces With the Lupus Foundation of America for a Star-studded Gala to Raise Awareness for Lupus
4. Better Lupus Treatments on the Horizon
5. Stars Shine on Butterflies Over Hollywood for Lupus Foundation of America
6. Clinical Trials for Lupus Underway After Decades of Drought
7. October is Lupus Awareness Month
8. New Round of Lupus Research Institute Awards Brings Promise of More Breakthroughs
9. Photo: New York Goes Orange for Pumpkin Festival and Lupus Awareness Month
10. Mayo Clinic shows therapy effective for reducing lupus flares
11. Research suggests targeted treatment strategies for lupus
Post Your Comments:
(Date:11/27/2015)... ... 2015 , ... An inventor, from Hopkinsville, Ky., thought there ... home, so he invented the patent-pending ELECTRONIC M.D. , The ELECTRONIC M.D. provides ... so, it could help to prevent potential overdose situations. As a result, it ...
(Date:11/27/2015)... Aliso Viejo, CA (PRWEB) , ... November 27, 2015 , ... ... exclusively for use in Final Cut Pro X. With ProSidebar: Fasion, video editors ... banners, or use ProSidebar as a minimalist title opener. Utilize presets featuring self-animating ...
(Date:11/27/2015)... ... November 27, 2015 , ... A simply groundbreaking television ... an interesting show that delves into an array of issues that are presently affecting ... benefit from open dialogue, this show is changing the subjects consumers focus on, one ...
(Date:11/27/2015)... ... November 27, 2015 , ... The men and ... nonprofit healthcare organizations in the country. They have overseen financial turnarounds, shown commitment ... advance the healthcare industry as a whole through their advocacy and professional efforts. ...
(Date:11/26/2015)... ... November 26, 2015 , ... Patients at Serenity Point ... come together on Thanksgiving Day to share the things that they are most ... Serenity Point YouTube channel, patients displayed what they wrote on index cards, describing ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... 2015  Lannett Company, Inc. (NYSE: LCI ... acquisition of Kremers Urban Pharmaceuticals Inc. (KU), the ... company UCB S.A. (Euronext: UCB). ... KU from UCB for total consideration of approximately ... customary working capital adjustment, a deduction of certain ...
(Date:11/27/2015)... 26, 2015 ... the "2016 Global Tumor Marker Testing ... and Sales Segment Forecasts, Innovative Technologies, Instrumentation ... to their offering. --> ... "2016 Global Tumor Marker Testing Market: ...
(Date:11/26/2015)... Un nuevo enfoque combina la ... cáncer avanzado.   --> Un nuevo ... Bremachlorin para el cáncer avanzado.   --> ... la terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... --> Clinical Cancer Research . --> ...
Breaking Medicine Technology: